NR1H4 and metabolic syndrome: Thus, not only activation of FXR with CDCA protects against development of dyslipidemia caused by ritonavir, but feeding ritonavir to FXR−/− mice resulted in an exacerbation of biochemical derangements caused by the HIV PI in wild type mice.